Assignee
SUN PHARMA ADVANCED RES CO LTD
IN·43 granted patents·33 pending applications·268 citations·filing 2002–2024
Top patents by PatentIndex Score
76 records- 0195USD583463SInhalerSUN PHARMA ADVANCED RES CO LTD·Filed 2007·Granted Dec 23, 2008·83 cites·1 claims
- 0294US11931359B2Method of increasing bioavailability and/or prolonging ophthalmic action of a drugSUN PHARMA ADVANCED RES CO LTD·Filed 2022·Granted Mar 19, 2024·2 cites·22 claims
- 0392US11951106B2Method of increasing bioavailability and/or prolonging ophthalmic action of a drugSUN PHARMA ADVANCED RES CO LTD·Filed 2021·Granted Apr 9, 2024·2 cites·19 claims
- 0492US11890375B2Ophthalmic solution of difluprednateSUN PHARMA ADVANCED RES CO LTD·Filed 2021·Granted Feb 6, 2024·2 cites·22 claims
- 0592USD577815SInhalerSUN PHARMA ADVANCED RES CO LTD·Filed 2007·Granted Sep 30, 2008·68 cites·1 claims
- 0691US11058684B2Method of increasing bioavailability and/or prolonging ophthalmic action of a drugSUN PHARMA ADVANCED RES CO LTD·Filed 2018·Granted Jul 13, 2021·4 cites·19 claims
- 0789US12409175B2Method of increasing bioavailability and/or prolonging ophthalmic action of a drugSUN PHARMA ADVANCED RES CO LTD·Filed 2024·Granted Sep 9, 2025·0 cites·14 claims
- 0889US8012496B2Gastric retention controlled drug delivery systemSUN PHARMA ADVANCED RES CO LTD·Filed 2010·Granted Sep 6, 2011·25 cites·1 claims
- 0987US11103451B2Ophthalmic solution of difluprednateSUN PHARMA ADVANCED RES CO LTD·Filed 2016·Granted Aug 31, 2021·3 cites·17 claims
- 1087US11000475B2Ophthalmic solution of difluprednateSUN PHARMA ADVANCED RES CO LTD·Filed 2016·Granted May 11, 2021·3 cites·15 claims
- 1187US9642811B2Abuse deterrent immediate release biphasic matrix solid dosage formSUN PHARMA ADVANCED RES CO LTD·Filed 2015·Granted May 9, 2017·3 cites·7 claims
- 1286US10172852B2Method of increasing bioavailability and/or prolonging ophthalmic action of a drugSUN PHARMA ADVANCED RES CO LTD·Filed 2015·Granted Jan 8, 2019·5 cites·19 claims
- 1385US11014915B2Selective estrogen receptor degraderSUN PHARMA ADVANCED RES CO LTD·Filed 2020·Granted May 25, 2021·3 cites·13 claims
- 1484US11857683B2Stabilization of phenobarbital sodium for injectionSUN PHARMA ADVANCED RES CO LTD·Filed 2022·Granted Jan 2, 2024·1 cites·25 claims
- 1584US9616029B2Abuse deterrent immediate release coated reservoir solid dosage formSUN PHARMA ADVANCED RES CO LTD·Filed 2015·Granted Apr 11, 2017·2 cites·3 claims
- 1683US10849887B2Treatment of Parkinson's diseaseSUN PHARMA ADVANCED RES CO LTD·Filed 2017·Granted Dec 1, 2020·2 cites·7 claims
- 1783US7776345B2Gastric retention controlled drug delivery systemSUN PHARMA ADVANCED RES CO LTD·Filed 2002·Granted Aug 17, 2010·25 cites·16 claims
- 1882US12383496B2Ophthalmic solution of difluprednateSUN PHARMA ADVANCED RES CO LTD·Filed 2024·Granted Aug 12, 2025·0 cites·20 claims
- 1981US10512608B2Nanoparticulate compositionSUN PHARMA ADVANCED RES CO LTD·Filed 2016·Granted Dec 24, 2019·5 cites·8 claims
- 2081US7964216B2Spaced drug delivery systemSUN PHARMA ADVANCED RES CO LTD·Filed 2002·Granted Jun 21, 2011·13 cites·15 claims
- 2179US11465990B2Heterocyclic antiestrogensSUN PHARMA ADVANCED RES CO LTD·Filed 2020·Granted Oct 11, 2022·1 cites·11 claims
- 2279US11351123B2Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazideSUN PHARMA ADVANCED RES CO LTD·Filed 2018·Granted Jun 7, 2022·1 cites·9 claims
- 2377US10150733B2Amidoheteroaryl aroyl hydrazide ethynesSUN PHARMA ADVANCED RES CO LTD·Filed 2016·Granted Dec 11, 2018·6 cites·4 claims
- 2477US2024066014A1Treatment for parkinson's diseaseSUN PHARMA ADVANCED RES CO LTD·Filed 2023·Application pending·0 cites
- 2574US11813252B2Treatment for Parkinson's diseaseSUN PHARMA ADVANCED RES CO LTD·Filed 2022·Granted Nov 14, 2023·0 cites·4 claims
- 2673US10123943B2Portable device for cutting a capsuleSUN PHARMA ADVANCED RES CO LTD·Filed 2017·Granted Nov 13, 2018·3 cites·8 claims
- 2771US10865199B2Heterocyclic antiestrogensSUN PHARMA ADVANCED RES CO LTD·Filed 2016·Granted Dec 15, 2020·1 cites·9 claims
- 2869US9539262B2Ophthalmic composition comprising a prostaglandinSUN PHARMA ADVANCED RES CO LTD·Filed 2015·Granted Jan 10, 2017·1 cites·1 claims
- 2968US11583522B2Treatment for Parkinson's diseaseSUN PHARMA ADVANCED RES CO LTD·Filed 2020·Granted Feb 21, 2023·0 cites·3 claims
- 3068US2024082161A1Stabilization of phenobarbital sodium for injectionSUN PHARMA ADVANCED RES CO LTD·Filed 2023·Application pending·0 cites
- 3166US12194153B2Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n′-(2-chloro-6-methyl-benzoyl) hydrazideSUN PHARMA ADVANCED RES CO LTD·Filed 2021·Granted Jan 14, 2025·0 cites·22 claims
- 3265US11559487B2Drug loaded nanoresin particlesSUN PHARMA ADVANCED RES CO LTD·Filed 2019·Granted Jan 24, 2023·0 cites·15 claims
- 3365US9980917B2Abuse deterrent immediate release coated reservoir solid dosage formSUN PHARMA ADVANCED RES CO LTD·Filed 2017·Granted May 29, 2018·0 cites·6 claims
- 3464US2025041437A1Humanized muc1 antibody and antibody drug conjugateSUN PHARMA ADVANCED RES CO LTD·Filed 2024·Application pending·0 cites
- 3562US2009208572A1Oral controlled release tabletSUN PHARMA ADVANCED RES CO LTD·Filed 2009·Application pending·0 cites
- 3660US2011003816A1Ophthalmic compositionSUN PHARMA ADVANCED RES CO LTD·Filed 2009·Application pending·0 cites
- 3758US12527792B2Stable multiparticulate pharmaceutical composition of rosuvastatinSUN PHARMA ADVANCED RES CO LTD·Filed 2021·Granted Jan 20, 2026·0 cites·11 claims
- 3858US2020000803A1Stable multiparticulate pharmaceutical composition of rosuvastatinSUN PHARMA ADVANCED RES CO LTD·Filed 2019·Application pending·0 cites
- 3957US11241443B2Ophthalmic solution of bimatoprostSUN PHARMA ADVANCED RES CO LTD·Filed 2018·Granted Feb 8, 2022·0 cites·1 claims
- 4057US11225480B2Malic enzyme inhibitorsSUN PHARMA ADVANCED RES CO LTD·Filed 2020·Granted Jan 18, 2022·0 cites·11 claims
- 4157US2024316039A1Method of reducing elevated intraocular pressureSUN PHARMA ADVANCED RES CO LTD·Filed 2022·Application pending·0 cites
- 4257US2024000802A1Difluprednate for reducing the adverse effects of ocular inflammationSUN PHARMA ADVANCED RES CO LTD·Filed 2021·Application pending·0 cites
- 4357US2011166101A1MicroparticlesSUN PHARMA ADVANCED RES CO LTD·Filed 2009·Application pending·0 cites
- 4457US2024316049A1Stabilization of phenobarbital sodium for injectionSUN PHARMA ADVANCED RES CO LTD·Filed 2023·Application pending·0 cites
- 4556US2024307300A1An improved process for the preparation of an aqueous ophthalmic solution of difluprednateSUN PHARMA ADVANCED RES CO LTD·Filed 2021·Application pending·0 cites
- 4656US2022127266A1Malic enzyme inhibitorsSUN PHARMA ADVANCED RES CO LTD·Filed 2022·Application pending·0 cites
- 4756US2025275953A1Vodobatinib for reducing progression of parkinson's diseaseSUN PHARMA ADVANCED RES CO LTD·Filed 2023·Application pending·0 cites
- 4855US2017189339A1Abuse deterrent immediate release biphasic matrix solid dosage formSUN PHARMA ADVANCED RES CO LTD·Filed 2017·Application pending·0 cites
- 4955US2021261534A1Selective estrogen receptor degraderSUN PHARMA ADVANCED RES CO LTD·Filed 2021·Application pending·0 cites
- 5054US11273126B2Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N′-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amideSUN PHARMA ADVANCED RES CO LTD·Filed 2018·Granted Mar 15, 2022·0 cites·5 claims
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SUN PHARMA ADVANCED RES CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →